Skip to content

A Clinical Trail on Ayurvedic formulation in the management of Abnormal Uterine Bleeding.

Role of Khanda Kushmanda Avaleha and Kutajadi Rasakriya in the management of Asrugdara with special reference to Abnormal Uterine Bleeding - A randomised comparative clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/042336
Enrollment
30
Registered
2022-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients complaining of As�gdarawith any two of the following features: �तिप�?रा��?र�?य�ण� [Heavy menstrual bleeding] (amount >80ml) Amount more than 80 ml will be assessed by pictorial blood loss assessment chart score 100. द�र�?��ालान�?बन�?ध�न �त�?�ालम {Prolonged menstrual bleeding} &/or (With the duration of bleeding >7 days) �न�त�?�ाल [Inter menstrual bleeding or Frequent menstrual cycle (interval �न�?यद�?र��?तल��?षणात वातपित�?त�फत�?रिद�ष� �स�?र��?दर (features different from normal menstrual blood.) Patients of age group 12 to 50 years.

Exclusion criteria

Exclusion criteria: Patient having Menopausal bleeding. Patients having bleeding due to abortion and childbirth. Patients having coagulation disorders. Patient having genital malignancy. Patients having STDs. Patients having any severe systemic diseases. Uterine and pelvic pathology like- Polyps, Endometrial Tuberculosis, Fibroid, Adenomyosis, Pelvic inflammatory disease etc. Patients using Intra uterine contraceptive device. Recently vaccinated for Covid-19 {within 3 months}. Bleeding from other than vaginal route.

Design outcomes

Primary

MeasureTime frame
Achievement of Å?huddha Ä?rtava Lakshana.Timepoint: 2 MONTHS

Secondary

MeasureTime frame
Optimize the heavy menstrual blood flow, associated generalized body ache and pain during menstruation. Improvement in generalized weakness. Timepoint: 2 MONTH

Countries

India

Contacts

Public ContactDr Sonu

National Insititude of Ayurveda Deemed to be University Jaipur

drsonamjangidnia@gmail.com8946854230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026